216 related articles for article (PubMed ID: 2896551)
1. [Psychopharmaceuticals as instruments for research].
Vinar O
Cesk Psychiatr; 1988 Feb; 84(1):28-35. PubMed ID: 2896551
[No Abstract] [Full Text] [Related]
2. [Dimensional approach to trans-nosographic study of psychotropic drugs].
Jouvent R
Encephale; 1995 Feb; 21 Spec No 1():39-43. PubMed ID: 7729355
[No Abstract] [Full Text] [Related]
3. [Neurotransmitters and behavioral disorders].
Allain H; Schuck S
Encephale; 1998 Jul; 24 Spec No 1():34-7. PubMed ID: 9809253
[No Abstract] [Full Text] [Related]
4. [Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
Lesch KP; Beckmann H
Nervenarzt; 1993 Jan; 64(1):75-9. PubMed ID: 8094894
[No Abstract] [Full Text] [Related]
5. Anatomic and molecular principles of psychopharmacology. A primer for psychiatrists.
Heckers S; Konradi C
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):1-22. PubMed ID: 10674188
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in neurobiology: Part III. Effectors of transmitter action.
Hyman SE
Psychosomatics; 1988; 29(4):373-8. PubMed ID: 2906447
[No Abstract] [Full Text] [Related]
7. Brain endocoid identification as a strategy for the development of a new generation of psychoactive drugs.
Costa E
Prog Clin Biol Res; 1985; 192():29-36. PubMed ID: 3001758
[No Abstract] [Full Text] [Related]
8. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy].
Wunderlich H; Wunderlich HP
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615
[No Abstract] [Full Text] [Related]
9. [Research on receptors and their psychiatric perspectives].
Munkvad I; Braestrup C
Nord Med; 1983; 98(11):274-7. PubMed ID: 6140671
[No Abstract] [Full Text] [Related]
10. Why Monitor Molecules in Neuroscience?
Andrews AM
ACS Chem Neurosci; 2017 Feb; 8(2):211-212. PubMed ID: 28196419
[No Abstract] [Full Text] [Related]
11. Presynaptic receptors and neurotransmission.
Langer SZ
Med Biol; 1978 Oct; 56(5):288-91. PubMed ID: 30867
[No Abstract] [Full Text] [Related]
12. [Cholecystokinin receptors. A target for tomorrow's psychopharmaceuticals?].
Zachrisson O; Lindefors N
Lakartidningen; 1996 Mar; 93(13):1225-7. PubMed ID: 8656838
[TBL] [Abstract][Full Text] [Related]
13. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment.
Lara DR; Akiskal HS
J Affect Disord; 2006 Aug; 94(1-3):89-103. PubMed ID: 16712943
[TBL] [Abstract][Full Text] [Related]
14. [Receptors for neurotransmitters and psychiatric diseases].
Wetzel H; Benkert O
Internist (Berl); 1988 Jun; 29(6):420-9. PubMed ID: 2900223
[No Abstract] [Full Text] [Related]
15. [The future of biological psychiatry].
Linnoila M
Duodecim; 1985; 101(17):1732-7. PubMed ID: 2865128
[No Abstract] [Full Text] [Related]
16. [Neurotransmitters: gender's differences].
Dazzi F; Scicchitano C
Riv Psichiatr; 2014; 49(5):237-4. PubMed ID: 25424337
[TBL] [Abstract][Full Text] [Related]
17. [The impact of molecular biology on psychiatric diseases].
Salín-Pascual RJ; Alcocer Castillejos N
Rev Invest Clin; 2003; 55(2):216-9. PubMed ID: 12827930
[No Abstract] [Full Text] [Related]
18. Multiple signals in synaptic transmission: impact on the strategies for the development of a new generation of centrally active drugs.
Costa E
Adv Biochem Psychopharmacol; 1987; 43():35-49. PubMed ID: 2884820
[No Abstract] [Full Text] [Related]
19. Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.
Greenshaw AJ
J Psychiatry Neurosci; 2003 Jul; 28(4):247-50. PubMed ID: 12921219
[No Abstract] [Full Text] [Related]
20. Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology.
Hyman SE
Psychosomatics; 1988; 29(3):254-63. PubMed ID: 2900534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
